Featured,Trends & Articles New Study Shows Psilocybin Alters How Brain Integrates Tactile Sensory Inputs By Dennis Mutua August 02, 2021 A recently conducted double-blind placebo-controlled neuroimaging study appears to be suggesting that psilocybin changes the way in which the brain processes tactile sensations and mental representations in the body of an individu...
Featured,Spotlight Stock,Trends & Articles ‘Nose-to Brain’ Drug Delivery System Being Developed to Aid Mental Health Treatments Using Psychedelics By Dennis Mutua July 30, 2021 A new nose-to-brain drug delivery method dubbed ‘novel sol-gen intranasal drug delivery technology’ is being developed by researches from various companies to help with the treatment of patients suffering from mental health di...
Featured,Trends & Articles Oregon Medical Board Establishes Magic Mushrooms Can Help to Reduce Anxiety and Depression By Dennis Mutua July 28, 2021 A report published by Oregon medical researchers, establishes that the hallucinogenic properties of magic mushrooms have the ability to effectively treat or reduce anxiety and depression. The results on this study released on J...
Spotlight Stock,Trends & Articles Awakn Life Sciences Commences Trading on OTC Market By Dennis Mutua July 27, 2021 Biotechnology company conducting clinical studies focusing on researching, developing and delivering psychedelics to cure addiction Awakn Life Sciences Corp. (NEO: AWKN) (OTC Pink: AWKNF) has commenced trading on the OTC Market in...
Featured,Spotlight Stock,Trends & Articles Field Trip Receives Conditional Approval to List on Nasdaq By Dennis Mutua July 26, 2021 Biotechnology company specializing on development and delivery of psychedelics therapies Field trip Health Ltd (TSX: FTRP) (OTCQX: FTRPF) announced having received conditional approval to get listed on Nasdaq Stock Market LLC unde...
Featured,Spotlight Stock,Trends & Articles Aion Combining Psychedelics and Cannabinoids Therapies to Treat Cancer By Dennis Mutua July 23, 2021 Life Sciences company focusing on research and production of medical cannabis and psychedelic-assisted therapies Aion Therapeutics Inc. (CSE: AION) is combining the healing powers of cannabinoids and psychedelics to treat depressi...
Featured,Trends & Articles Rahn & Associates Launches Tailor Made Risk Management Solution For Psychedelics Companies By Dennis Mutua July 22, 2021 Global insurance broker specializing on insurance products and services for highly regulated and complex industries and assets Rahn & Associates has launched a new risk management solution which is specifically designed for ps...
Featured,Trends & Articles Psilocybin May Help Patients Suffering From Obesity Says Expert By Dennis Mutua July 21, 2021 Clive Ward Able, MD, BPharm, the president of Clintell and a consultant to NeoMind Biosciences Inc. (CSE: NEON) says that a recently study he conducted proved that psilocybin can help patients suffering obesity who have tried othe...